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ABSTRACT Membrane pores spontaneously formed by antimicrobial peptides in membranes were crystallized for the first
time by manipulating the sample hydration and temperature. Neutron diffraction shows that magainins and protegrins form
stable pores in fully hydrated fluid membranes. At lower hydration levels or low temperature, the membrane multilayers
crystallize. In one crystalline phase, the pores in each bilayer arrange in a regular hexagonal array and the bilayers are stacked
into a hexagonal ABC lattice, corresponding to the cubic close-packed structure of spheres. In another crystalline phase, the
bilayers are modulated into the rippled multilamellae, corresponding to a 2D monoclinic lattice. The phase diagrams are
described. Crystallization of the membrane pores provides possibilities for diffraction studies that might provide useful
information on the pore structures.
INTRODUCTION
One remaining major challenge in structural biology is
solving the structures of proteins and protein assemblies in
membranes. In recent years, we have made progress in
detecting and analyzing the structures of peptide assemblies
in fluid membranes by neutron diffraction (He et al., 1995,
1996a; Ludtke et al., 1996; Yang, L. et al., 1998, 1999).
These experiments were performed with membranes in the
form of oriented multilayers. Originally the samples were
investigated in full hydration so that the physical properties
of the lipid bilayers were close to the physiological condi-
tions. However, it was soon realized that the sample hydra-
tion is a useful experimental parameter. New phenomena of
peptide-lipid interactions were discovered when the sample
hydration was varied. In general, in full hydration, the
peptide organization in each lipid bilayer is uncorrelated to
the neighboring bilayers. However as the hydration level
decreases, the peptide organizations become correlated be-
tween bilayers, even though the membranes are still fluid. In
many cases, further dehydration strengthens the correlation
such that the peptide organization in the multilayers crys-
tallizes (Yang, L. et al., 1999). This was a rather unexpected
result. The crystals are not those of the peptides alone. They
are crystals of peptide-lipid assemblies within lipid bilayers.
Such crystals have not been reported before. These new
phases provide the possibilities for diffraction studies of
supramolecular peptide assemblies in lipid bilayers. In this
paper, we will describe an efficient way of controlling the
sample hydration to investigate the crystalline phases using
neutron or x-ray diffraction. A facility capable of rapid,
continuous change of the sample hydration is essential for
this experiment. We will describe the crystal phases we
have observed and the phase diagrams of the crystalline
phases for two antimicrobial peptides in phospholipid bi-
layers. The crystalline samples are thin and are supported on
a substrate that presents a challenge to diffraction studies.
This problem will also be discussed.
Antimicrobial peptides are inducible innate host defense
molecules found first in insects (Steiner et al., 1981) and
subsequently in all multicellular organisms that were inves-
tigated, including humans and plants (Ganz and Lehrer,
1998; Hoffmann et al., 1999). These peptides are typically
20 to 40 amino acids long, with a folded size comparable to
the membrane thickness. All evidence indicates that anti-
microbial peptides act by permeabilizing the cell mem-
branes of microorganisms (see reviews in Boman et al.,
1994), although, in addition, receptor-mediated signaling
activities of some peptides have been reported (Yang, D. et
al., 1999; Hoffmann et al., 1999). In particular, synthetic
all-D amino acid enantiomers of the peptides, including
magainin (Wade et al., 1990; Bessalle et al., 1990) and
protegrin (Yasin et al., 1996; Cho et al., 1998), have exhib-
ited the same antimicrobial spectrum as their all-L native
peptide counterparts. This indicates that the action of anti-
microbial peptides does not involve stereo-specific protein
receptors; rather, the action is the result of direct interaction
with the lipid matrix of the plasma membrane.
All the peptides we have investigated, including alam-
ethicin (Huang and Wu, 1991), magainins (Ludtke et al.,
1994), protegrins (Heller et al., 1998), and melittin (Har-
roun, 1999), exhibit two distinct oriented circular dichroism
(OCD) spectra (Wu et al., 1990) when they are bound to
membranes, one at low peptide-to-lipid ratios (P/L) and
another at high P/L. This indicates that each peptide has two
distinctly different physical states of binding to a mem-
brane. The transition from the low to the high P/L state takes
place over a narrow range of P/L as if there is a threshold
concentration, called P/L* (Huang and Wu, 1991; Heller et
al., 1998). P/L* for each peptide varies greatly with the lipid
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composition of the membrane (Huang and Wu, 1991;
Ludtke et al., 1994; Heller et al., 1998). At concentrations
below P/L*, the peptides are embedded in the lipid head
group region, called the surface state, as suggested by the
peptide orientation and the membrane thinning effect (Wu
et al., 1995; Ludtke et al., 1996; Heller et al., 2000). At
concentrations above P/L*, neutron in-plane scattering
showed that the peptides form pores in the membranes,
whereas no pores were detected below P/L* (He et al., 1995,
1996a; Ludtke et al., 1996). The majority of the peptides at
concentrations above P/L* are in the pore state. Pore for-
mation in such high densities is stable, contrary to what is
observed in single-channel experiments where extremely
low peptide concentrations are used and the pore formations
are fluctuation phenomena (Christensen et al., 1988; Duch-
ohier et al., 1989; Sokolov et al., 1999). The pores observed
by neutron have diameters of20 Å or larger. Massive pore
formations are apparently lethal if they occur in cell mem-
branes. We concluded that pore formation is the mode of
action of antimicrobial peptides, and the control of P/L* by
the cell membrane’s lipid composition could be the gating
mechanism (He et al., 1996b; Ludtke et al., 1996; Heller et
al., 1998, 2000; Huang, 2000).
The direct observation of pores in fluid membranes is
important, because it is related to the physiological condi-
tion of membranes. This was achieved by exploiting the
sensitivity of neutron to D2O, which had replaced the water
in the membrane pores. However, diffraction from the fluid
state allowed only an estimate of the pore size (He et al.,
1996a). The diffraction signals from fluid membranes were
limited to a low range of q (the momentum transfer of
scattering), which made detailed structural analyses of the
pores difficult. To understand the energetics of the pore
formation and the gating mechanisms of the antimicrobials’
activity, it is imperative to know the structures of the pores.
Thus, we believe that the discovery of the crystalline phase
is an important new development for the field of antimicro-
bial peptides.
Two peptides isolated from animals were selected for in-
vestigation by this novel approach. Magainin 2 (NH2-Gly-Ile-
Gly-Lys-Phe5-Leu-His-Ser-Ala-Lys10-Lys-Phe-Gly-Lys-
Ala15-Phe-Val-Gly-Glu-Ile20-Met-Asn-Ser-CONH2) is a
23-residue peptide secreted by the skin of the African
clawed frog Xenopus laevis (Zasloff, 1987). In vitro, it
exhibits broad-spectrum antibacterial, antifungal, and tu-
moricidal activities (Zasloff, 1987; Cruciani et al., 1991). Pro-
tegrin-1 (PG-1) (NH2-Arg-Gly-Gly-Arg-Leu
5-Cys-Tyr-Cys-
Arg-Arg10-Arg-Phe-Cys-Val-Cys15-Val-Gly-Arg-CONH2) is
an 18-amino acid peptide isolated from the leukocytes of pigs
(Kokryakov et al., 1993). In vitro, PG-1 can kill many bacteria,
including Escherichia coli, Listeria monocytogenes, and Neis-
seria gonorrhoeae (Kokryakov et al., 1993; Harwig et al.,
1996; Qu et al., 1996, 1997). It is also active against the fungus
Candida albicans (Kokryakov et al., 1993; Cho et al., 1998)
and can protect cells from infection by human immunodefi-
ciency virus (Tamamura et al., 1995). One synthetic analogue
of PG-1, IB367 (NH2-Arg-Gly-Gly-Leu-Cys
5-Tyr-Cys-Arg-
Gly-Arg10-Phe-Cys-Val-Cys-Val15-Gly-Arg-CONH2), is also
included for comparative studies. It is apparent that all these
peptides have potential for pharmaceutical applications.
Magainin and protegrin represent two major classes of
antimicrobial peptide structures. Magainin 2 adopts a pri-
marily -helical secondary structure upon binding to mem-
branes (Matsuzaki et al., 1989; Williams et al., 1990;
Ludtke et al., 1994). On the other hand, the NMR solution
structure of PG-1 is a one-turn  hairpin in which the four
cysteines form two disulfide bonds that stabilize the  sheet
structure like two rungs of a ladder (Aumelas et al., 1996;
Fahrner et al., 1996). It is reasonable to assume that this
solution structure remains essentially unchanged when
PG-1 binds to membranes, although this is yet to be shown
by experiment. We also assume that the analogue IB-367
has the same conformation as PG-1, based on their analogy
in amino acid sequence and the similarity between their CD
spectra (Heller et al., 1998, and unpublished data).
EXPERIMENTAL
Magainin 2 amide was a gift from Drs. Michael Zasloff and
W. Lee Maloy of Magainin Pharmaceuticals, Inc. (Ply-
mouth Meeting, PA). Protegrin-1 and its synthetic analogue,
IB367, were a gift from Dr. John Fiddes of IntraBiotics
Pharmaceuticals, Inc. (Mountain View, CA). 1,2-Dimyris-
toyl-sn-glycero-3-phosphatidylcholine (DMPC) and 1,2-
dimyristoyl-sn-glycero-3-phosphatidylglycerol (DMPG)
were purchased from Avanti (Alabaster, AL). Quartz plates
of 21 mm diameter and 0.25 mm thickness were purchased
from Chemglass (Vineland, NJ). Silicon wafers with (100)
surface were purchased from Semiconductor Processing
(Boston, MA). All other chemicals were reagent grade. All
materials were used as delivered.
Neutron diffraction
Sample preparation
The key to this experiment is a novel sample configura-
tion. Its design was based on the following considerations.
Neutron experiment typically requires a large amount of
sample. The amount is determined by the signal-to-noise
ratio, which increases proportionally to the square root of
the scan time. For practical purposes, it is desirable to limit
the collection time for a complete diffraction pattern of a
sample to within 1 hour. Using the SANS beamline NG3 of
the National Institute of Standards and Technology (NIST;
Gaithersburg, MD) as a reference, this means that each
sample requires at least 10 mg of lipid at the peptide-to-lipid
molar ratios P/L  1/40 to 1/10. This amount of peptide-
lipid mixture will be spread over several quartz plates, each
with a sample area300 mm2, so the total sample thickness
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is about 30 m. In our previous experiments, we divided
50 mg sample into 6 or 7 separate layers and sandwiched
each layer between two quartz plates (He et al., 1996a).
Samples in this form can be aligned into uniformly oriented
multilamellae, parallel to the substrate surfaces, by a num-
ber of techniques (Powers and Pershan, 1977; Huang and
Olah, 1987). Most of our previous neutron experiments
were performed with such sandwiched samples (He et al.,
1995, 1996a; Ludtke et al., 1996; Yang, L. et al., 1998,
1999). However, it would take hours or days to change the
hydration level of a sandwiched sample, too long for the
conduct of a neutron experiment if hydration change is
desired. In recent years, we have developed procedures for
preparing thin oriented samples on a single substrate
(Ludtke et al., 1995). Exposing such an open sample to a
controlled water vapor pressure, one can change its hydra-
tion level within minutes. Open samples have been used in
our lab for OCD experiments (Heller et al., 1997, 1998) and
x-ray experiments (Ludtke et al., 1995; Chen et al., 1997;
Harroun et al., 1999; Heller et al., 2000). However, the
samples for OCD and x-ray experiments are typically 1 m
thick. It was not clear before this experiment if thick (5
m) samples can be aligned by the one-substrate prepara-
tion. Here we report the use of one-substrate sample for
neutron experiment for the first time. All samples were
prepared in conditions that have been examined by OCD
previously, and the measurements indicated that the pep-
tides were in the inserted state (Ludtke et al., 1994; Heller
et al., 1998).
Quartz plates were cleaned abrasively and then soaked in
a heated bath of sulfuric acid and chromic acid mixture for
15 to 20 min, followed by repeated washing with distilled
H2O and ethanol. Two micrograms of the lipid-peptide
mixture was deposited on one plate from a stock solution of
organic solvent. The concentration of the stock solution was
10 mg/ml (lipid/solvent). As described in Ludtke et al.
(1995), the final distribution of the material on the quartz
surface depends strongly on the solvent used. The solution
should have an appropriate surface tension with an appro-
priate evaporation rate to produce a uniform coating. We
found that combinations of trifluoroethanol and chloroform
worked for DMPC/magainin and DMPC/protegrin mix-
tures. For each sample composition, the ratio between the
two solvents must be adjusted, by trial and error, to obtain
the best results. The deposit dried to a visually smooth and
uniform coating on the surface of the quartz plate. The
sample was then placed in a freeze-dryer to remove any
remaining trace of solvent. Six quartz plates, each with a
uniform coating of the peptide-lipid mixture, were stacked
in a pile. An aluminum spacer around the edge of the plate
kept the plates from touching each other, and it also pro-
vided good thermal contact between the sample and the
temperature-controlled sample mount. The space between
plates allowed the deposited peptide-lipid multilayers to be
in direct contact with water vapor. The stacked pile was
positioned in the neutron beam so that the quartz plates were
first oriented perpendicular to the beam, then rotated by an
angle  with respect to an axis parallel to the plates and
through the center of sample (see the sample geometry in
Fig. 1 of Yang et al., 1998). The neutron beam was adjusted
to a diameter of 8 mm. Care was taken to keep the alumi-
num spacers out of the neutron beam to avoid small-angle
scattering signals from aluminum.
Temperature/humidity chamber
During the neutron experiment, the sample was housed in
a temperature/humidity chamber equipped with quartz win-
dows to allow the passage of incident and scattered neutron
beam. The chamber consists of a sample mount at the
center, which allows the sample to rotate as described, a pair
of temperature and humidity probes, and a water bath. The
construction is covered by two boxes, one inside the other
so the inside box is thermally insulated from room temper-
ature. The temperature and humidity controls are feedback
circuits that respond to the outputs of the temperature and
humidity probes. The feedback circuits provide heating or
cooling using thermoelectric modules (Melcor Electronics
Corp., Trenton, NJ). The temperature controller maintains
the temperature of the sample mount. The device for the
humidity control heats or cools a small water bath (D2O was
used in neutron experiment) that is positioned away from
the sample mount. The temperature probe is an AD590
two-terminal IC temperature transducer, calibrated at 0°C
with a mixture of ice and water and at 35°C with a cali-
brated Fisher digital thermometer. The probe was in direct
contact with the sample mount. The relative humidity probe
is model EMD-2000 (General Eastern Instruments,
Woburn, MA). The relative humidity (RH) was calculated
based on the impedance-RH table provided with the probe.
In the chamber, the probe was positioned close to the
sample. The humidity control heats or cools the water bath
if the probe is lower or higher, respectively, than the set
value for humidity. This device changes the temperature and
humidity to a set value within minutes. The neutron diffrac-
tion pattern of the sample changed with temperature and
humidity instantaneously. It remained unchanged after the
temperature and humidity reached the set values. The tem-
perature of the sample mount can be controlled to within
0.1°C. The RH in the vicinity of sample can be controlled
to within 0.5% RH in most cases.
X-ray diffraction
For x-ray diffraction experiment, 1 mg of peptide-lipid
mixture was deposited on a silicon wafer over an area 10 
30 mm2. A point source of Cu K radiation (operating at 35
mA/40 kV) was used. A thin Ni filter was placed at the tube
exit to remove most of the Cu K radiation. The beam was
then focused by a pair of spherically bent x-ray mirrors
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(Charles Supper Co., MA). The mirrors were Ni-coated to
further reduce the amount of K radiation. A temperature/
humidity chamber similar to the neutron device described
above was positioned on a goniometer head. X-ray diffrac-
tion was recorded on a Siemens X1000 multiwire propor-
tional chamber (512  512 pixel; Bruker AXS Inc., Mad-
ison, WI) at the sample-to-detector distance of 21.54 cm.
The distance was measured using sucrose powder as a
calibration standard. A cone-shaped helium path covered
the space between the chamber and the detector. X-ray
samples were oriented at a grazing angle. Data collection
time depends on the amount and quality of the sample. It is
usually 20 min.
Two main differences between x-ray and neutron diffrac-
tion are: (1) Neutron, with the use of D2O, is sensitive to
both the fluid and crystalline states of membranes. X-ray is
sensitive only to the crystalline state of membranes. (2)
X-ray diffraction was measured by the reflection mode. It is
difficult to find a suitable substrate that is transparent to
x-ray. In contrast, quartz substrate is essentially transparent
to neutron, hence both the transmitted and reflected neutron
were recorded.
The techniques of measuring diffraction patterns from
oriented multilayers have been described in two recent
publications (Yang, L. et al., 1998, 1999). In particular, the
full procedure for data reduction is given in Yang et al.
(1998).
RESULTS AND DISCUSSION
In a previous paper (Yang, L. et al., 1999) we reported how
the diffraction pattern of a magainin sample changed with
hydration. When the membranes were fluid and fully hy-
drated, the diffraction pattern usually had a peak on the qr
axis (qz  0). (qz and qr are the projections of the momen-
tum transfer of neutron or x-ray scattering perpendicular
and parallel to the plane of bilayers, respectively.) This was
interpreted as a result of in-plane scattering of D2O-filled
pores that were moving randomly in each bilayer. The
in-plane positions of the pores in fluid membranes were
uncorrelated between adjacent bilayers. When the hydration
level was slightly less than full, the diffraction peak shifted
off the qz 0 line (Fig. 1 B1, left panel). This means that the
in-plane positions of the pores became correlated between
adjacent bilayers, even though the diffraction was otherwise
fluid-like, indicating that the bilayers were still in the fluid
state. The cause of this correlation was speculated to be the
hydration force (Yang, L. et al., 1999). Upon further dehy-
dration or cooling, the correlation became long-range, and
the diffraction pattern turned into sharp peaks (Fig. 1 B1,
middle and right panels). Note that the diffraction peaks
shown in the middle panel of Fig. 1 B1 appeared to emerge
directly from the fluid-like broad bands shown in the left
panel as the sample was dehydrated or cooled, indicating
that the scattering objects are the same for these two pat-
terns. When the hydration and/or temperature were de-
creased further, the crystal pattern in the middle panel
turned into another crystal pattern, shown in the right panel.
Within the ranges of temperature and hydration we explored
in this experiment (see the phase diagram below), magainin
in DMPC exhibited three phases: fluid phase and two crys-
talline phases of different symmetry.
The crystalline phases are not unique to magainin. Pro-
tegrin and its analogue, IB-367, also produced similar crys-
FIGURE 1 Neutron diffraction patterns of magainin, protegrin-1, and
IB367 in DMPC. (A) Raw data on the area detector produced by magainin
in DMPC at the peptide-to-lipid molar ratio (P/L) 1/30, measured at the
sample tilt angle   75° (see the diffraction geometry in Yang et al.,
1998). The patterns were not centered because the detector was displaced
transversely to the beam direction to extend the q range. (B1) The raw data
shown in A were translated to the qz–qr plane. As temperature and/or the
hydration level decreased from left to right, the sample showed three
distinct patterns: membrane pores in fluid bilayers (left panel), crystalline
of hexagonal ABC stacking (middle panel), and crystalline of 2D mono-
clinic (right panel). (B2) Three patterns of protegrin-1 in DMPC (P/L 
1/30). Note that the sequence of appearance for the hexagonal ABC
stacking and the 2D monoclinic is reversed, compared with magainin. (B3)
Three patterns of protegrin analogue IB367 in DMPC (P/L  1/30). Note
that the sequence is the same as magainin, but different from protegrin-1.
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talline patterns (Fig. 1, B2 and B3). In contrast, no such
patterns by alamethicin samples have been observed so far.
Perhaps this indicates that protegrins and magainin form the
same type of membrane pores (the toroidal pores; see
Ludtke et al., 1996), differing from that of alamethicin (the
barrel-stave pores; see He et al., 1996a). However, as will
be discussed below, the phase diagram of protegrin is very
different from that of magainin.
Hexagonal ABC stacking
The crystal pattern shown in the middle panel of Fig. 1 B1
was examined over a wider q range by x-ray. The diffraction
pattern on the area detector is shown in Fig. 2 A, left. The
pattern was translated to the qr–qz plane by the method de-
scribed in Yang et al. (1998) in Fig. 2 A, right. To understand
this diffraction pattern, imagine equivalent magainin pores
arranged on a regular hexagonal lattice in each bilayer. Fig. 3
shows a schematic for such a lattice on a realistic scale. The
size of the magainin pores was determined by the analysis of
in-plane scattering (Ludtke et al., 1996). The pore structure
was a conjecture, based on indirect evidence, in which the
lipids bend continuously from the top to the bottom monolayer
through the pore (the toroidal model) with approximately
seven magainin monomers (the cylinders in the figure) packed
in the lipid head group region around the hole (Ludtke et al.,
1996). The orientation of the helical peptide was determined
by OCD (Ludtke et al., 1994). Note that the pores in Fig. 3 are
shown rotationally disordered, which may be the case in real
samples. The lattice constant (denoted as a in Eq. 1 below) is
determined by the diffraction data shown in Fig. 2. Let the
repeat spacing of the bilayer stacking be c. It is well known that
for close-packed layers of spheres, there are two ways of
arranging the stacking to create periodic arrays of minimum
interstitial volume, i.e., the ABCABC. . . stacking (see Fig. 2
A, bottom) corresponding to the cubic close-packed structure,
or, alternatively, the ABAB. . . stacking corresponding to the
hexagonal close-packed structure (Kittel, 1971). In our case,
there is no obvious reason for the bilayers to stack in the
manner of close-packed spheres. Yet the diffraction pattern
shown in Fig. 2 A is exactly that of ABC stacking. The crystal
axes of ABC stacking (Fig. 2 A, bottom) are
a1 a, 0, 0, a2  a2 , 32 a, 0,
a3 a2 , a23 , c. (1)
FIGURE 2 X-ray diffraction patterns of magainin in 3:1 DMPC/DMPG (P/L  1/30). The patterns are the same as those produced by magainin in pure
DMPC bilayers but stronger in intensity. (A) The crystalline phase of hexagonal ABC stacking is shown on the detector (left) and translated to the qz–qr
plane (right). The bottom shows a hexagonal close-packed layer of pores (circles), with centers marked A. A second and identical layer can be placed over
the first, with centers over the points marked B. There are two nonequivalent choices for a third layer; it can go in over A or over C. The data are consistent
with the ABCABC. . . packing. The reciprocal lattice points generated by ABC packing are shown in red circles on the qz-qr plane; they coincide precisely
with the data points. The hexagonal indices HK  L for the reciprocal lattice points are also labeled. (B) The crystalline phase of 2D monoclinic is shown
on the detector (left) and translated on the qz-qr plane (right). The bottom shows the unit cells of 2D monoclinic lattice, that has the same symmetry as the
modulated lamellar (rippled) phase P shown schematically in gray lines (Wack and Webb, 1989). The reciprocal lattice points generated by 2D monoclinic
lattice are shown in red circles on the qz-qr plane; they coincide precisely with the data points.
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Hence, the corresponding reciprocal vectors (Warren, 1969)
are
b1 1a , 13 1a ,  23 1c , b2 0, 23 1a ,  13 1c ,
b3 0, 0, 1c .
(2)
The reciprocal lattice points generated by Eq. 2 are shown
in Fig. 2 A, right. They coincide precisely with the diffrac-
tion peaks. Note that for close-packed spheres, c is related to
a by c  	2/3a. In our case there is no apparent relation
between c and a, and the space lattice is not cubic. We will
call it the hexagonal ABC stacking.
2D monoclinic
The pattern shown in the right panel of Fig. 1 B1 was
reexamined by x-ray over a wider q range. The resulted
diffraction pattern on the area detector is shown in Fig. 2 B,
left, and translated to the qz–qr plane in Fig. 2 B, right. The
pattern conforms to the symmetry of a 2D monoclinic
lattice, described by the crystal axes:
a1 a,0,0, a3 ccot,0,c , (3)
where  is the monoclinic angle. The corresponding recip-
rocal vectors (Warren, 1969) are
b1 1a , 0,  cota  , b3 0, 0, 1c . (4)
All the diffraction peaks coincide with the reciprocal lattice
points generated by the vectors of Eq. 4 (Fig. 2 B). This
pattern is the same as the modulated lamellar (rippled)
phase P of phospholipids (Wack and Webb, 1989). In the
rippled phase, c is the period of layer stacking and a is ripple
wavelength.
Phase diagrams
Fig. 4 shows preliminary RH-T phase diagrams for ma-
gainin and protegrin. The phase boundaries are not well
defined due to hysteresis and occasional coexistence of two
phases. Note that, for magainin, the sequence of phase
appearance when the sample was dehydrated and/or cooled
is fluid3 hexagonal ABC3 2D monoclinic. However, for
protegrin, the sequence is fluid 3 2D monoclinic 3 hex-
agonal ABC. Even more surprising, the phase sequence of
the protegrin analogue IB367 is unlike PG-1, but is similar
to magainin (not shown). The significance of this phase
reversal is unknown at the moment.
FIGURE 3 A schematic of magainin pores in a lipid bilayer crystallized
into a regular hexagonal lattice. The size of the pores and the lattice
constant are according to the data. The pore structure was a conjecture
based on indirect evidence (Ludtke et al., 1996) in which the toroidal pores
of lipid bilayer are stabilized by the magainin monomers (the cylinders)
packed in the lipid head group region. Note that we assume that the pores
are rotationally disordered.
FIGURE 4 RH-T phase diagrams of (A) magainin in DMPC (P/L 
1/30) and (B) protegrin-1 in DMPC (P/L  1/30). The circles represent the
fluid phase in which water-filled pores move randomly in each bilayer (this
phase was described in details in Yang, L. et al., 1999). The squares
represent the crystalline phase of hexagonal ABC stacking. The diamonds
represent the crystalline phase of 2D monoclinic. Overlaid symbols indi-
cate hysteresis.
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The phase diagrams show that each crystalline phase
covers a substantial range of RH. This will allow us to use
the swelling method (Blaurock, 1971) to determine the
phases of x-ray diffraction amplitudes. If the pores are
rotationally disordered, the unit cell is centrosymmetrical,
that is, symmetrical with respect to the inversion transfor-
mation. In this case the phase of each diffraction amplitude
is either 0 or , or, equivalently, the amplitude is either
positive or negative (Liu et al., 1991). Changing hydration
in each phase will vary the period of stacking c and, there-
fore, vary the qz of the diffraction peaks. The sign of the
amplitude can often be determined by the trend with which
the magnitude of the amplitudes varies (Torbet and Wilkins,
1976).
DISCUSSION
The immediate application of these crystalline phases is to
obtain the projection structures of the membrane pores. The
ultimate structure resolution (or the highest orders of dif-
fraction) obtainable is still unknown. The complete diffrac-
tion data, once obtained, can be used to construct the elec-
tron density map of the unit cell. The models of the pore can
then be compared with the data at the resolution obtained.
It is important to note that neutron, with the use of D2O,
is the only technique capable of detecting the peptide pores
in fluid membranes. X-ray diffraction of peptide structures
in fluid membranes is very weak, insufficient for analysis.
However, the crystalline phases are more easily studied with
x-ray because of their shorter wavelength and higher inten-
sity compared with neutron. In principle, the crystalline
phases can also be studied with electron microscopy; how-
ever, special sample preparations may be required (Reimer,
1997).
The presence of a substrate as a part of an oriented
membrane sample presents a problem for x-ray diffraction.
As shown in Fig. 2, if the diffraction is measured in the
reflection mode, the peaks close to the qr axis (i.e., qz  0)
are not detectable. In contrast, in-plane diffraction is easily
obtained by neutrons because the substrate (quartz) is trans-
parent to neutrons, both the reflected and transmitted neu-
trons are detectable. Unfortunately, crystallographic diffrac-
tion with neutrons is impractical due to other problems, such
as incoherent scattering and the weakness of neutron beam
intensity. In order to obtain the complete x-ray diffraction
pattern, we are currently investigating techniques of mea-
surement using the transmission mode.
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